Our Clients

Biotechnology and Pharmaceutical

Affinium Pharmaceuticals (Canada)
Apothogen
Axcan Pharmaceuticals (Canada)
Debiopharm (Switzerland)
Defender Pharmaceuticals
Galleon Pharmaceuticals
Glaxo, Inc.
Glaxo Wellcome, Inc.
Glaxo Wellcome plc (UK/global)
GlaxoSmithKline, Inc.
Grifols Inc
IntraBiotics
Ironshore Pharmaceuticals Inc
Karos Pharmaceuticals Inc.
KEJ Pharmaceuticals
Maabarot Products (Israel)
Matrivax
MicuRx Inc. (China)

Neuromed Development Inc
Nobelex Pharmaceuticals (Canada)
Oriel Therapeutics
Osmol Therapeutics
Oxford GlycoSciences Plc (UK)
Peninsula Pharmaceuticals
Percept Bio
Procter & Gamble Company
Protez Pharmaceuticals
Reliant Pharmaceuticals
Rhamnopharma Inc
Shire Pharmaceuticals
SmithKline Beecham
Spherix, Inc.
Synthon Pharmaceuticals (Netherlands)
Talecris Inc
United Therapeutics
ZWI Therapeutics

Device and Diagnostic Companies

Chem Glo LLC
Invitrox Inc.
Medtronics

Venture Capital, Investment Bankers and Financial Institutions

J.P. Morgan Partners
Perseus Soros
Thomas, Knight, Trent, King & Company

BioPharma has many contacts with VCs in US and Europe. In addition, we have supported due diligence activities for JP Morgan Partners and Perseus Soros.

Testimonials

"I was initially attracted to BioPharma Consultants’ solid track record and the quality of their contacts in our industry. We’ve perhaps benefited most from the widely diverse perspectives the firm brings — big business vs. entrepreneurial, technical vs. marketing, conservative vs. untraditional."
- VP of Corporate Development, Development-Stage Pharmaceutical Company, USA
"BioPharma Consultants immediately built the trust and credibility that allowed me to feel comfortable letting go of their piece of the project. It sounds cliché, but their counsel and support really helped give me the peace of mind to sleep at night."
- VP of Corporate Development, Development-Stage Pharmaceutical Company, USA
Icons/chat-icon-blackCreated with Sketch.
"Leisa Dennehy combines rarely seen qualities — a powerful, questioning intellect, the ability to translate the ideas she uncovers into hard-hitting action and an interpersonal style that enthusiastically draws people together."
- VP of Corporate Development, Development-Stage Pharmaceutical Company, USA
"I was initially attracted to BioPharma Consultants’ solid track record and the quality of their contacts in our industry. We’ve perhaps benefited most from the widely diverse perspectives the firm brings — big business vs. entrepreneurial, technical vs. marketing, conservative vs. untraditional."
- VP of Corporate Development, Development-Stage Pharmaceutical Company, USA